Browse By Topic Clinical Microbiology
ASM Hails Game-Changing Investment in Genomic Surveillance Enacted in American Rescue Plan
ASM hails the inclusion of $1.75 billion for CDC’s Advanced Molecular Detection (AMD) program in the American Rescue Plan Act signed into law by President Biden.
ASM Responds to House Committee Hearing on COVID Response
ASM responds to the House Energy & Commerce Subcommittee on Health Hearing: “Road to Recovery: Ramping Up COVID-19 Vaccines, Testing and Medical Supply Chain."
Laboratory Supply Shortages Are Impacting COVID-19 and Non-COVID Diagnostic Testing
The high demand for COVID-19 testing has impacted lab supply chains since the pandemic's early days. Now, unprecedented supply shortages for non-COVID-19 tests are affecting diagnostic testing for many other diseases.